MedTrace Pharma A/S — Credit Rating and Financial Key Figures

CVR number: 36497661
Agern Alle 5 A, 2970 Hørsholm
connect@medtrace.dk
tel: 31388581
www.medtrace.dk
Free credit report See parent company

Income statement (kDKK)

2020
2021
2022
2023
2024
Fiscal period length1212121212
Net sales93.151 529.102 192.842 645.342 334.36
Other operating income1 413.14831.19173.86230.35107.40
Costs of manufacturing-1 155.57- 269.58- 606.28-2 098.28
Gross profit93.15373.531 923.262 039.06236.08
Costs of management- 986.42-12 721.21-15 944.00-5 016.13-5 933.03
Costs of distribution-27.16-1 319.84-5 328.70-5 687.41-3 327.78
Other operating expenses- 603.07-11 638.41-29 876.32-11 637.40-14 598.04
EBIT- 110.36-24 474.74-49 051.90-20 071.53-23 515.37
Other financial income33.3441.6370.683 505.464 004.40
Other financial expenses- 128.67- 445.15- 973.43-1 591.23-1 294.96
Pre-tax profit- 205.69-24 878.26-49 969.57-18 157.30-20 805.93
Income taxes590.607 026.5712 919.173 050.805 450.05
Net earnings384.91-17 851.68-37 050.40-15 106.50-15 355.88

Assets (kDKK)

2020
2021
2022
2023
2024
Intangible rights36 849.8062 658.3279 400.13149 702.73222 612.52
Intangible assets total36 849.8062 658.3279 400.13149 702.73222 612.52
Machinery and equipment3 703.626 512.567 888.847 342.0510 236.59
Other tangible assets773.112 002.2411 700.809 658.967 139.80
Tangible assets total4 476.728 514.8119 589.6417 001.0117 376.39
Other non-current investments116.18767.57-1 473.031 331.101 517.14
Investments total116.18767.57-1 473.031 331.101 517.14
Deferred tax assets2 426.86
Long term receivables total2 426.86
Inventories total404.084 307.235 996.822 462.30
Current trade debtors2 476.32
Current other receivables-1 922.593 337.8911 487.635 746.175 809.01
Current deferred tax assets1 922.595 500.005 500.005 500.005 500.00
Short term receivables total2 476.328 837.8916 987.6311 246.1711 309.02
Cash and bank deposits14 111.8738 333.3469 446.26122 317.4134 317.32
Cash and cash equivalents14 111.8738 333.3469 446.26122 317.4134 317.32
Balance sheet total (assets)58 030.89119 516.00190 684.72307 595.24289 594.69

Equity and liabilities (kDKK)

2020
2021
2022
2023
2024
Share capital1 354.052 010.492 716.084 996.835 000.66
Other reserves-47.35-70.49-85.41-90.50-66.48
Retained earnings32 082.60109 618.22195 610.31295 437.49280 486.43
Profit of the financial year384.91-17 851.68-37 050.40-15 106.50-15 355.88
Shareholders equity total33 774.2193 706.53161 190.57285 237.32270 064.73
Non-current loans from credit institutions4 165.105 484.203 749.571 006.49525.65
Non-current leasing loans139.3668.506 119.346 119.343 869.53
Non-current deferred tax liabilities6 577.625 069.35
Non-current liabilities total10 882.0710 622.059 868.917 125.834 395.18
Current loans from credit institutions4 896.25152.32609.28609.27
Current leasing loans639.73210.191 884.781 164.092 074.19
Current trade creditors1 293.139 141.603 267.136 278.844 795.44
Other non-interest bearing current liabilities6 545.50546.4712 171.575 415.786 472.39
Accruals and deferred income5 289.152 149.441 764.111 183.48
Current liabilities total13 374.6015 187.4119 625.2415 232.0915 134.78
Balance sheet total (liabilities)58 030.89119 516.00190 684.72307 595.24289 594.69
Try the full version of our system for free
Bankruptcy risk visualization example

... and more!

No registration needed.

Full version